Avrio MedTech
Deciphering the epileptic brain
Avrio MedTech (MedTech of the Future in Greek) develops diagnostic tools for intracranial EEG (iEEG, SEEG or grids) procedures, leveraging existing and new biomarkers such as high-frequency oscillations (HFO), including fast-ripples. We aim to improve the quality of life of patients suffering from drug-resistant epilepsy and help their neurologists understand their unique disease, better localize the brain regions responsible for their seizures and identify the best treatment options for them, without necessarily requiring a seizure to occur during the monitoring period.
At the moment, Avrio MedTech offers advanced intracranial EEG analyses for research-use only, with tools available both on our secured cloud and on premises.
We are your partner for any research program requiring advanced analyses of iEEG signals, including detection and characterization of HFOs, such as Fast ripples (FR) or ripples, epileptic spikes or seizures. We work with conventional clinical electrodes, but also with the latest generation of hybrid electrodes, which include microwires. We tailor our reports to your needs. Our ability to provide live quantitative information allows you to consider new adaptive treatments, whether using drugs or through neuromodulation.
We leverage Halyzia™, our patented AI-based solution.
We are proud to be a registered social economy company, whose internal operations and activities are based on a principle of solidarity and social utility.
Industry
Identify new therapeutic targets,
understand correlations between iEEG biomarkers and therapy responses
select patients most likely to respond
Researchers & clinicians
Include iEEG biomarkers in your multi-biomarker approaches
Design new adaptive treatments
Bring your innovations to the market
Include us as a partner in your consortium
Hospitals & clinicians
Be part of our network and get funding for your data
Sign up as a Halyzia™ beta user and help us get FDA-clearance and CE-marking